Skip to the page

Data / Drug companies / Nitroglycerin

Nitroglycerin: 40 companies and 106 products in the FDA NDC directory

Nitroglycerin is listed in the FDA National Drug Code Directory by 40 companies, with 106 products in commercial distribution. 67 of the products (63.2%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; patch; ointment, and the newest product started marketing on August 10, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
40
Products
106
Generic (ANDA) products
67 (63.2%)
Application numbers
22
Routes
Sublingual, Oral, Transdermal, Intravenous, Rectal
Brand names
Glonoinum, Nitro-Dur, Nitrostat, Nitro-Time, Rectiv, Nitrolingual, Nitro-Bid, Nitrostat
openFDA record search
api.fda.gov

Companies that list nitroglycerin

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Boiron8pelletUnapproved homeopathic productsMarch 3, 1983
Dr. Reddy's Laboratories Inc.7patch; tabletAuthorized generics (NDA)March 1, 2020
HF Acquisition Co LLC, DBA HealthFirst6tablet; sprayGeneric drugs (ANDA)December 2, 2024
Ingenus Pharmaceuticals, LLC6patchNew drug applications (NDA)December 6, 2017
Medical Purchasing Solutions, LLC6tabletGeneric drugs (ANDA)September 1, 2024
A-S Medication Solutions4tabletGeneric drugs (ANDA)February 2, 2024
Mylan Pharmaceuticals Inc.4patchGeneric drugs (ANDA)June 18, 1998
Advagen Pharma Ltd3tabletGeneric drugs (ANDA)May 3, 2021
Aurobindo Pharma Limited3tabletGeneric drugs (ANDA)October 26, 2023
Baxter Healthcare Corporation3injectionNew drug applications (NDA)December 29, 1989
Glenmark Pharmaceuticals Inc., USA3tabletGeneric drugs (ANDA)September 19, 2017
Golden State Medical Supply, Inc.3tabletGeneric drugs (ANDA)August 26, 2016
Lifestar Pharma LLC3tabletGeneric drugs (ANDA)December 5, 2023
Mylan Pharmaceuticals Inc.3tabletAuthorized generics (NDA)August 26, 2016
Natco Pharma USA LLC3tabletGeneric drugs (ANDA)October 3, 2022
NuCare Pharmaceuticals,Inc.3tabletGeneric drugs (ANDA)September 1, 2024
Remedyrepack Inc.3tablet; injection, solutionGeneric drugs (ANDA)February 5, 2025
Solco Healthcare US, LLC3tabletGeneric drugs (ANDA)June 1, 2025
Time Cap Laboratories, Inc3capsuleOther unapproved drugsJune 19, 2014
Viatris Specialty LLC3tabletNew drug applications (NDA)June 4, 2024
Encube Ethicals, Inc.2ointmentGeneric drugs (ANDA)April 16, 2025
Padagis Israel Pharmaceuticals Ltd2spray; ointmentGeneric drugs (ANDA)August 10, 2026
ProPharma Distribution2tablet; injectionGeneric drugs (ANDA)September 19, 2017
Proficient Rx LP2tabletGeneric drugs (ANDA)October 3, 2022
Redpharm Drug2tabletGeneric drugs (ANDA)September 1, 2024
Sportpharm LLC2spray; tabletAuthorized generics (NDA)December 2, 2024
Allegis Pharmaceuticals, LLC1sprayAuthorized generics (NDA)July 1, 2019
Allergan, Inc.1ointmentNew drug applications (NDA)June 21, 2011
American Regent, Inc.1injection, solutionGeneric drugs (ANDA)March 4, 2003
Bryant Ranch Prepack1ointmentGeneric drugs (ANDA)January 8, 2026
Cosette Pharmaceuticals, Inc.1ointmentGeneric drugs (ANDA)February 23, 2024
Henry Schein, Inc.1injection, solutionGeneric drugs (ANDA)January 13, 2022
Independence Pharmaceuticals, LLC1sprayNew drug applications (NDA)December 2, 2024
NorthStar RxLLC1tabletGeneric drugs (ANDA)September 1, 2024
Prasco Laboratories1sprayAuthorized generics (NDA)December 2, 2024
Proficient Rx LP1tabletNew drug applications (NDA)May 1, 2000
Proficient Rx LP1tabletGeneric drugs (ANDA)August 29, 2016
Savage Laboratories a Division of Fougera Pharmaceuticals, LLC1ointmentGeneric drugs (ANDA)August 15, 2009
Solaris Pharma Corporation1ointmentGeneric drugs (ANDA)January 8, 2026
TruPharma, LLC1ointmentGeneric drugs (ANDA)December 2, 2024

Dosage forms

Dosage formProductsShare
Tablet5753.8%
Patch1413.2%
Ointment109.4%
Pellet87.5%
Spray65.7%
Injection43.8%
Injection, solution43.8%
Capsule32.8%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)6763.2%
New drug applications (NDA)1817%
Authorized generics (NDA)109.4%
Unapproved homeopathic products87.5%
Other unapproved drugs32.8%

Pharmacologic classes

ClassProducts
Nitrate Vasodilator106

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.